Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation.

@article{Googe2011RandomizedTE,
  title={Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation.},
  author={Joseph M Googe and Alexander J. Brucker and Neil M. Bressler and Haijing Qin and Lloyd Paul Aiello and Andrew N. Antoszyk and Roy W Beck and Susan B. Bressler and Frederick L. Ferris and Adam R. Glassman and Dennis M. Marcus and Cynthia R Stockdale},
  journal={Retina},
  year={2011},
  volume={31 6},
  pages={1009-27}
}
PURPOSE To evaluate 14-week effects of intravitreal ranibizumab or triamcinolone in eyes receiving focal/grid laser for diabetic macular edema and panretinal photocoagulation. METHODS Three hundred and forty-five eyes with a visual acuity of 20/320 or better, center-involved diabetic macular edema receiving focal/grid laser, and diabetic retinopathy receiving prompt panretinal photocoagulation were randomly assigned to sham (n = 123), 0.5-mg ranibizumab (n = 113) at baseline and 4 weeks, and… CONTINUE READING